Myeloid cell–mediated killing of B-ALL by CD38 and CD20 IgA antibody variants is enhanced by CD47/SIRPα interference

Authors:

Lustig M, Kowol M, Hartmann AM, van der Peet IC, Jansen MJH, Iben K, Winterberg D, Krohn S, Baumann N, Rösner T, Bendig S, Hahn C, Wurm AA, Gehlert CL, Denker M, Suwanchaikasem P, Macarrón Palacios A, Schwartz S, Brüggemann M, Burger R, Schmitt K, Klausz K, Valerius O, Stölzel F, Bastian L, Baldus CD, Peipp M, Leusen JHW, Schewe DM, Valerius T.
Journal:

Blood Neoplasia
Year of publication:

2026
Citation:

May 5;3(3):100242
doi:

10.1016/j.bneo.2026.100242
PubMed: PubMed (PMID: 42327600)
Impact factor:

–
Abstract:

–

Participating Institutes